The US Food and Drug Administration cleared a test that detects Chlamydia trachomatis and Neisseria gonorrhoeae in roughly 30 minutes, for use in point-of-care settings.
On February 27, 2021, the US Food and Drug Administration issued an emergency use authorization (EUA) for the Janssen COVID-19 vaccine. This is the third vaccine authorized by the FDA to prevent COVID-19.
...
The FDA has approved Humira (Adalimumab) for the treatment of moderately to severly active ulcerative colitis (UC) in pediatric patients aged 5 years or older.
The US Food and Drug Administration has issued an emergency use authorization for a new combination of monoclonal antibodies for treating patients with mild to moderate COVID-19 who are at risk of...
A new therapeutic agent added to standard of care significantly improves outcomes for patients with serious complication of systemic lupus erythematosus.
The FDA has approved a new option for the treatment of HIV-1 in adults as a replacement for current antiretroviral regimens in patients who are virologically suppressed and with no history of treatment...
The FDA released a letter to clinical providers warning that several molecular tests for COVID-19 may result in false negatives and offers recommendations.
